Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,871 | -7,106 | -9,986 | -5,191 | -10,752 |
| Depreciation Amortization | N/A | N/A | 6 | 3 | 2 |
| Accounts receivable | -432 | -998 | 372 | -8,834 | 1,163 |
| Accounts payable and accrued liabilities | -1,519 | -89 | 1,082 | 709 | 1,254 |
| Other Working Capital | 62 | 395 | 4,076 | -4,576 | 5,840 |
| Other Operating Activity | 3,752 | 2,082 | 3,338 | 12,229 | -164 |
| Operating Cash Flow | $-13,008 | $-5,716 | $-1,112 | $-5,660 | $-2,657 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,041 | 2,479 | 8,979 | 5,482 | N/A |
| Common Stock Repurchased | -42 | -42 | N/A | N/A | N/A |
| Other Financing Activity | -83 | -61 | 0 | -106 | 0 |
| Financing Cash Flow | $3,916 | $2,376 | $8,979 | $5,376 | $N/A |
| Beginning Cash Position | 50,501 | 50,501 | 42,634 | 42,634 | 42,634 |
| End Cash Position | 41,409 | 47,161 | 50,501 | 42,350 | 39,977 |
| Net Cash Flow | $-9,092 | $-3,340 | $7,867 | $-284 | $-2,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,008 | -5,716 | -1,112 | -5,660 | -2,657 |
| Free Cash Flow | -13,008 | -5,716 | -1,112 | -5,660 | -2,657 |